Two differently substituted pyrazole ligands have been investigated with regard to the topology of their Pt complexes: upon deprotonation, two mononuclear 1:2 PtII-pyrazole complexes—one sterically unhindered 4-Me-pzH and one bulky 3,5-tBu-pzH (pzH = pyrazole)—yield corresponding PtII-pyrazolato species; former a triangular, trinuclear metallacycle (1), latter dinuclear, half-lantern species (2...

BACKGROUND Pyrazole and pyrazolone motifs are well known for their wide range of biological activities such as antimicrobial, anti-inflammatory, and antitumor activities. The incorporation of more than one pharmacophore in a single scaffold is a well known approach for the development of more potent drugs. In the present investigation, a series of differently substituted 4-arylidene pyrazole de...

Zolo1, 2-apyrazole-1-one or its salts are used as a hair dye with red. In addition, pyrazolo3, 4-cpyrazoles are useful for the treatment of.novel glucosyl pyrazole derivatives starting from D-glucose. Pyrazoles are chemical compounds of synthetic origin that.Pyrazoles: Synthetic Strategies and Their Pharmaceutical. Abstract: Pyrazoles are an important class of five membered heterocyclic compoun...

A set of pyrazole-bridged bis(imidazolium) compounds [H3L]X2 – [H3L]X2 (L1 = 3,5-bis[1-(tert-butyl)imidazolium-1-ylmethyl]-1H-pyrazole; L2 = 3,5-bis[1-(tert-butyl)imidazolium-1-ylmethyl]-4-phenyl-1H-pyrazole; L3 = 3,5-bis[1-(1-adamantyl)imidazolium-1-ylmethyl]-1Hpyrazole; L4 = 3,5-bis[1-(1-adamantyl)imidazolium-1-ylmethyl]-4-phenyl-1H-pyrazole; X = Cl−, BF4− or PF6−) has been prepared, and thre...

In the title compound, [Zn(C(8)H(3)NO(6))(C(8)H(7)N(3))(2)(H(2)O)]·0.5H(2)O, the Zn(II) atom shows a distorted octa-hedral ZnN(4)O(2) coordination environment and is bonded to two 3-(2-pyrid-yl)-1H-pyrazole ligands via the N atoms, one monodentate 4-nitro-phthalate ligand and one associated water mol-ecule. Additionally, one water of crystallization, with a site-occupation factor of 0.5, is pre...

In the mol-ecule of the title compound, C(20)H(19)N(5)O, the pyrazole and oxadiazole rings are not completely conjugated, the dihedral angle between them being 7.97 (6)°. The pyrazole and oxadiazole rings form dihedral angles of 42.74 (6) and 4.35 (5)° with the attached phenyl and benzene rings, respectively.

Aminoindanol-derived thioureas catalyze proton transfer and do not stabilise anions in an asymmetric conjugate addition to pyrazole crotonate. Calculations show that the urea H-bonds play different roles in the preferred transition state and in the one leading to the minor enantiomer in the mechanism of hydroxy-thiourea catalyzed conjugate additions to pyrazole crotonates.

The title compound, C(20)H(26)N(2)O(5), was prepared in good yield (76%) through condensation of diethyl (4-meth-oxy-benz-yl)propane-dioate with 3,5-dimethyl-1H-pyrazole. The dihedral between the benzene and pyrazole rings is 83.96 (10)°. The crystal packing is stabilized by a C-H⋯O inter-action, which links the mol-ecules into centrosymmetric dimers.

An oxo-bridged diruthenium(III) complex containing pyrazolato and pyrazole ligands is stable against ascorbic-acid reduction, induces apoptosis (60%, 48 h) against HeLa cells at 10 microM level and exhibits promising anti-angiogenic activity at its sub-cytotoxic concentrations. Other mononuclear ruthenium(III) complexes containing pyrazole ligands [Ru(pz)(4)X(2)](+) exhibit dual anti-angiogenic...

The title compound, C(22)H(20)ClN(3), is composed of a dialkyl-substituted pyrazole ring connected to an aryl-substituted isoquinoline ring system with a dihedral angle of 55.8 (1)° between the pyrazole ring and and the isoquinoline ring system. The dihedral angle between the chloro-phenyl ring and the isoquinoline ring system is 28.3 (1)°.